Intracranial stenting with wingspan: Still awaiting a safe landing

Stroke

Volumn 42, Issue 7, 2011, Pages 1809-1811

  Abou Chebl, Alex ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

intracranial disease; intracranial stenosis; prevention; stenting

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; NADROPARIN; NIMODIPINE;

BRAIN ANGIOGRAPHY; BRAIN ATHEROSCLEROSIS; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBRAL REVASCULARIZATION; CLINICAL PROTOCOL; CLINICAL TRIAL; DISEASE SEVERITY; ENDOVASCULAR SURGERY; FOLLOW UP; GENERAL ANESTHESIA; HUMAN; IN STENT STENOSIS; INTRACRANIAL ATHEROSCLEROTIC DISEASE; INTRACRANIAL STENOSIS; MORTALITY; PATIENT SELECTION; PERIOPERATIVE COMPLICATION; PRIORITY JOURNAL; REPEAT PROCEDURE; RESTENOSIS; REVIEW; RISK ASSESSMENT; STENT; STENT THROMBOSIS; STROKE; TARGET LESION REVASCULARIZATION; TRANSIENT ISCHEMIC ATTACK;

ANGIOPLASTY, BALLOON; CARDIOLOGY; ENDOVASCULAR PROCEDURES; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; RISK; SAFETY; STENTS; TREATMENT OUTCOME;

EID: 79959955187     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.620229     Document Type: Review

References (9)

1. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305-1316.
2. Fiorella D, Turk AS, Levy EI, Pride GL, Woo HH, Albuquerque FC, et al. US Wingspan Registry: 12-month follow-up results. Stroke. 2011;42: 1976-1981.
3. Jiang WJ, Yu W, Du B, Gao F, Cui LY. Outcome of patients with <70% symptomatic intracranial stenosis after wingspan stenting. Stroke. 2011;42. In press.
4. Abou-Chebl A, Lin R, Hussain MS, Jovin TG, Levy EI, Liebeskind DS, et al. Conscious sedation versus general anesthesia during endovascular therapy for acute anterior circulation stroke: preliminary results from a retrospective, multicenter study. Stroke. 2010;41:1175-1179.
5. Mazighi M, Yadav JS, Abou-Chebl A. Durability of endovascular therapy for symptomatic intracranial atherosclerosis. Stroke. 2008;39:1766-1769.
6. Popma JJ, Berger P, Ohman EM, Harrington RA, Grines C, Weitz JI. Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:576S-599S. (Pubitemid 39302605)
7. Meyers PM, Higashida RT, Phatouros CC, Malek AM, Lempert TE, Dowd CF, et al. Cerebral hyperperfusion syndrome after percutaneous transluminal stenting of the craniocervical arteries. Neurosurgery. 2000; 47:335-343.
8. Kobayashi Y, Honda Y, Christie GL, Teirstein PS, Bailey SR, Brown CL, et al. Long-term vessel response to a self-expanding coronary stent: a serial volumetric intravascular ultrasound analysis from the ASSURE Trial. A stent vs stent ultrasound remodeling evaluation. J Am Coll Cardiol. 2001;37:1329-1334.
9. Kuntz RE, Baim DS. Defining coronary restenosis. Newer clinical and angiographic paradigms. Circulation. 1993;88:1310-1323. (Pubitemid 23264052)